Mirae Asset Global ETFs Holdings’s Bioventus BVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$210K Buy
22,194
+244
+1% +$2.33K ﹤0.01% 2461
2026
Q1
$200K Buy
21,950
+510
+2% +$4.28K ﹤0.01% 2360
2025
Q4
$160K Sell
21,440
-260
-1% -$1.87K ﹤0.01% 2454
2025
Q3
$145K Sell
21,700
-3,547
-14% -$24.6K ﹤0.01% 2483
2025
Q2
$167K Buy
25,247
+2,199
+10% +$15.6K ﹤0.01% 2372
2025
Q1
$211K Buy
23,048
+1,538
+7% +$15.4K ﹤0.01% 2295
2024
Q4
$226K Buy
21,510
+912
+4% +$10.8K ﹤0.01% 2331
2024
Q3
$246K Buy
+20,598
New +$178K ﹤0.01% 2273

Other funds holding BVS

Mirae Asset Global ETFs Holdings's BVS Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Bioventus (BVS) stake by 1.1% in Q2 2026, buying an estimated $2.33K and bringing the position to 22,194 shares worth $210K. The position accounts for ﹤0.01% of the portfolio, ranked #2461.

Mirae Asset Global ETFs Holdings first reported a position in BVS in Q3 2024 and has held it in 8 quarters since. The position peaked at $246K in Q3 2024. 157 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 22,194 shares of Bioventus worth $210K as of Q2 2026.
  • Mirae Asset Global ETFs Holdings bought 244 Bioventus shares in Q2 2026, an estimated $2.33K.
  • Bioventus made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2461 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Bioventus in Q3 2024 and has held it in 8 quarters since.
  • Mirae Asset Global ETFs Holdings's Bioventus position peaked at $246K in Q3 2024.
  • 157 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.